Beijing Hotgen Biotech Co., Ltd. (688068) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Beijing Hotgen Biotech Co., Ltd.

Why is Beijing Hotgen Biotech Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 17.54% and Operating profit at -290.80% over the last 5 years

The company has declared negative results for the last 12 consecutive quarters

The company has declared negative results in Jun 22 after 6 consecutive negative quarters
NET PROFIT(9M) At CNY -151.04 MM has Grown at -137.14%
OPERATING CASH FLOW(Y) Lowest at CNY 59.92 MM
NET SALES(HY) At CNY 215.3 MM has Grown at -13.29%

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 223.75%, its profits have fallen by -89.8%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Beijing Hotgen Biotech Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Beijing Hotgen Biotech Co., Ltd.

223.75%

6.27

85.56%

China Shanghai Composite

14.77%

1.01

14.58%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

17.54%

EBIT Growth (5y)

-290.80%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.23

Sales to Capital Employed (avg)

0.26

Tax Ratio

4.10%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

40.14%

ROE (avg)

25.58%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

5.62

EV to EBIT

-66.80

EV to EBITDA

-114.28

EV to Capital Employed

7.90

EV to Sales

33.76

PEG Ratio

Dividend Yield

ROCE (Latest)

-11.82%

ROE (Latest)

-6.50%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -6.35% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at -22.71 %

PRE-TAX PROFIT(Q)

At CNY 2.95 MM has Grown at 108.03%

NET PROFIT(Q)

At CNY -0.95 MM has Grown at 97.95%

-19What is not working for the Company

NET PROFIT(9M)

At CNY -151.04 MM has Grown at -137.14%

OPERATING CASH FLOW(Y)

Lowest at CNY 59.92 MM

NET SALES(HY)

At CNY 215.3 MM has Grown at -13.29%

ROCE(HY)

Lowest at -7.03%

Here's what is working for Beijing Hotgen Biotech Co., Ltd.

Pre-Tax Profit

Highest at CNY 2.95 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Pre-Tax Profit

At CNY 2.95 MM has Grown at 108.03%

over average net sales of the previous four periods of CNY -36.69 MM

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY -0.95 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Net Profit

At CNY -0.95 MM has Grown at 97.95%

over average net sales of the previous four periods of CNY -46.53 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Debt-Equity Ratio

Lowest at -22.71 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost

Fallen by -6.35% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Beijing Hotgen Biotech Co., Ltd.

Net Sales

At CNY 92.61 MM has Fallen at -26.61%

over average net sales of the previous four periods of CNY 126.18 MM

MOJO Watch

Near term sales trend is extremely negative

Net Sales (CNY MM)

Operating Cash Flow

Lowest at CNY 59.92 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales

Lowest at CNY 92.61 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)